Professor Bill Mayew explores whether public companies have visibility into the macroeconomy to filter errors in GDP data—and what that means for economic forecasting Every quarter, the U.S. Bureau of Economic Analysis releases its initial GDP estimate—a flagship measure of economic health that influences corporate boardrooms, Federal Reserve policy, and investor portfolios. But there’s a catch: these early numbers are often wrong. In this episode, Professor Bill Mayew of Duke University’s Fu...
All content for Duke Fuqua Insights is the property of Duke University's Fuqua School of Business and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Professor Bill Mayew explores whether public companies have visibility into the macroeconomy to filter errors in GDP data—and what that means for economic forecasting Every quarter, the U.S. Bureau of Economic Analysis releases its initial GDP estimate—a flagship measure of economic health that influences corporate boardrooms, Federal Reserve policy, and investor portfolios. But there’s a catch: these early numbers are often wrong. In this episode, Professor Bill Mayew of Duke University’s Fu...
"What Happens When Drug Company Payments to Doctors Go Public?" w/ Prof Tong Guo
Duke Fuqua Insights
11 minutes
2 weeks ago
"What Happens When Drug Company Payments to Doctors Go Public?" w/ Prof Tong Guo
Professor Tong Guo explains how mandated transparency didn't reduce pharmaceutical payments to physicians—instead, it taught companies to optimize them. When the federal government mandated that pharmaceutical companies publicly disclose every payment to physicians—from conference sponsorships to consulting fees—policymakers expected transparency to reduce potential conflicts of interest. Instead, the payments kept flowing, and companies learned to optimize them. In this episode, Professor To...
Duke Fuqua Insights
Professor Bill Mayew explores whether public companies have visibility into the macroeconomy to filter errors in GDP data—and what that means for economic forecasting Every quarter, the U.S. Bureau of Economic Analysis releases its initial GDP estimate—a flagship measure of economic health that influences corporate boardrooms, Federal Reserve policy, and investor portfolios. But there’s a catch: these early numbers are often wrong. In this episode, Professor Bill Mayew of Duke University’s Fu...
